Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Critical Reviews in Oncology/Hematology|November 21, 2021
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patientsUmberto Malapelle, Sara Pilotto, Maria Lucia Reale, et al.
Oncotarget|November 22, 2017
Patients with NSCLC may display a low ratio of p.T790M <i>vs.</i> activating EGFR mutations in plasma at disease progression: implications for personalised treatmentMarzia Del Re, Paola Bordi, Iacopo Petrini, et al.
BMJ Open|January 12, 2026
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trialAlice Avancini, Diana Giannarelli, Stefano Ugel, et al.
International Journal of Molecular Sciences|August 12, 2022
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical StudyLaura Lupini, Roberta Roncarati, Lorenzo Belluomini, et al.
Frontiers in Oncology|September 12, 2025
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumabSerena Eccher, Marco Sposito, Ilaria Trestini, et al.
Therapeutic Advances in Medical Oncology|November 12, 2025
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevanceSara Pilotto, Lorenzo Belluomini, Federico Monaca, et al.
Frontiers in Oncology|July 15, 2021
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated CenterGiulia Pasello, Jessica Menis, Sara Pilotto, et al.
Cancers|November 14, 2023
Plasmacytoid Dendritic Cell, Slan<sup>+</sup>-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer PatientsFrancesca Pettinella, Chiara Lattanzi, Marta Donini, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 23, 2024
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational studyIlaria Trestini, Lorenzo Belluomini, Alessandra Dodi, et al.
Scientific Reports|October 6, 2025
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancerMarco Sposito, Lorenzo Belluomini, Riccardo Nocini, et al.
Pageof 10